Literature DB >> 18184329

Adeno-associated viral vector transduction of green fluorescent protein in kidney: effect of unilateral ureteric obstruction.

Keiichi Ito1, Jie Chen, Jonathan J Khodadadian, E Darracott Vaughan, Michael Lipkowitz, Dix P Poppas, Diane Felsen.   

Abstract

OBJECTIVE: To evaluate adeno-associated virus (AAV) mediated renal gene transfer, by examining the localization and time course of gene expression in the kidneys of mice with unilateral ureteric obstruction (UUO) and controls. AAV is a replication-defective virus that has the potential to deliver genes into the kidney to improve renal damage after UUO.
MATERIALS AND METHODS: An AAV vector carrying a green fluorescent protein (GFP) reporter gene (rAAV-GFP) was used. In control mice, GFP expression was evaluated at 4, 7, 14 and 28 days after intrapelvic injection of rAAV or phosphate-buffered saline (PBS). In mice with UUO, the left ureter was obstructed, and 24 h later either rAAV or PBS was injected; GFP expression was evaluated 4, 7 and 14 days later by direct fluorescence.
RESULTS: In the control mice, at least 7 days was required to detect GFP expression, whereas after UUO, GFP expression was already evident at 4 days after injection. GFP was localized mainly to the medullary tubules.
CONCLUSIONS: This study shows successful transduction of GFP into mouse kidney using an AAV vector; GFP was expressed sooner in UUO kidneys than in the controls. These results show the feasibility of using AAV to transduce GFP into the obstructed kidney, and suggest that it might be useful in transducing therapeutically active agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18184329     DOI: 10.1111/j.1464-410X.2007.07313.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  11 in total

1.  Gene therapy to the kidney using viral vectors.

Authors:  Talha Akbulut; Frank Park
Journal:  Paidiatrike       Date:  2008

Review 2.  Improving Molecular Therapy in the Kidney.

Authors:  Jeffrey D Rubin; Michael A Barry
Journal:  Mol Diagn Ther       Date:  2020-08       Impact factor: 4.074

3.  Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure.

Authors:  Prasad R Konkalmatt; Laureano D Asico; Yanrong Zhang; Yu Yang; Cinthia Drachenberg; Xiaoxu Zheng; Fei Han; Pedro A Jose; Ines Armando
Journal:  JCI Insight       Date:  2016-06-02

4.  Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vector.

Authors:  Xiaoyan Luo; Gentzon Hall; Songtao Li; Andrew Bird; Peter J Lavin; Michelle P Winn; Alex R Kemper; Talmage T Brown; Dwight D Koeberl
Journal:  Mol Ther       Date:  2011-07-05       Impact factor: 11.454

5.  rAAV6-mediated miR-29b delivery suppresses renal fibrosis.

Authors:  Suguru Saito; Shin-Ichiro Ohno; Yuichirou Harada; Keiki Oikawa; Koji Fujita; Shouichirou Mineo; Asako Gondo; Yoshihiko Kanno; Masahiko Kuroda
Journal:  Clin Exp Nephrol       Date:  2019-09-03       Impact factor: 2.801

6.  Comparison of Gene Delivery to the Kidney by Adenovirus, Adeno-Associated Virus, and Lentiviral Vectors After Intravenous and Direct Kidney Injections.

Authors:  Jeffrey D Rubin; Tien V Nguyen; Kari L Allen; Katayoun Ayasoufi; Michael A Barry
Journal:  Hum Gene Ther       Date:  2019-12-03       Impact factor: 5.695

7.  [A method for efficient transduction of miR-483-5p in the kidney of mice].

Authors:  Ying Xia; Xue-Juan Zhou; Wen-Qing Gu; Yan-Yan Zhao; Xiao Xiao; Xiao-Chun Bai; Jun Liu; Ming Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-02-20

8.  Efficient Gene Transfer to Kidney Mesenchymal Cells Using a Synthetic Adeno-Associated Viral Vector.

Authors:  Yoichiro Ikeda; Zhao Sun; Xiao Ru; Luk H Vandenberghe; Benjamin D Humphreys
Journal:  J Am Soc Nephrol       Date:  2018-07-05       Impact factor: 10.121

9.  Comparison of the transduction efficiency of tyrosine-mutant adeno-associated virus serotype vectors in kidney.

Authors:  Yan F Qi; Qiu H Li; Vinayak Shenoy; Michael Zingler; Joo Y Jun; Amrisha Verma; Michael J Katovich; Mohan K Raizada
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-01       Impact factor: 2.557

10.  rAAV9 combined with renal vein injection is optimal for kidney-targeted gene delivery: conclusion of a comparative study.

Authors:  C J Rocca; S N Ur; F Harrison; S Cherqui
Journal:  Gene Ther       Date:  2014-05-01       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.